From Fortunereview How Hi can Opk go?
Dec 27, 2016 20:29:01 GMT
via mobile
stcks, icemandios, and 1 more like this
Post by miamianne67 on Dec 27, 2016 20:29:01 GMT
Opko Health, Inc. (NASDAQ:OPK), with 1.53% gains in previous 5 sessions, is under coverage of 5 analysts who collectively assign a buy rating on stock. 4 of the brokerages firms have a buy or better rating; the 0 sells versus 0 underperforms. The 5 stock analysts who cover the stock have an average PT at $16.2, with individual targets in the range of $10 to $22. The shares ended last trade at $11.91, implying that Wall Street analysts see shares climbing about 36.02 per cent in 12 months’ time.
Insider Trading News: Insiders at the company look optimistic about the outlook as they seem to accumulate shares while they have 18.51 jumped so far this year. A CEO & Chairman, 10% Owner at Opko Health, Inc. (OPK) purchased shares in a trading activity completed on Friday December 02, 2016. Frost Phillip Md Et Al accumulated 1,000 shares in the company at a per-share price of $10.49 and ended up spending $10,490 in the investment. Frost Phillip Md Et Al now have 184,000,000 shares in the stock after this transaction. A CEO & Chairman, 10% Owner in the company, Frost Phillip Md Et Al, on Thursday December 01, 2016 spent $39,030 from the purchase of 3,800 shares at a per-share price of $10.49. Insiders are expected to have better knowledge about the health and prospects of their company, which is why insiders’ move deserves attention.
Historical Quarterly Earnings: Last quarter, Opko Health, Inc. generated nearly $298.04M in sales and net income of -$0.03/share. That compares with the mean forecast $322M and -$0.03/share, respectively. For the prior quarter revenue for the stock hit $357.1M, with EPS at $0.02.
Opko Health, Inc. (OPK) Analyst Rating News
Standpoint Research is following shares of Opko Health, Inc. (OPK), so its rating change is noteworthy. The company stock was initiated at Buy, wrote analysts at Standpoint Research, in a research note issued to clients on Friday June 03, 2016. There was another key research note provided by JP Morgan on Friday October 16, 2015. The firm launched coverage on OPK at Overweight.
Price Potential: Even though the stock has posted 2.85% rise in value, its new closing price reflects a -1.98% fall in value from company’s one year high of $12.15. The stock is currently holding above its 50-day SMA of $10.73 and above its 200-day SMA of $10.03. Over the last 3 months and over the last 6 months, the shares of Opko Health, Inc. (OPK), have changed 7.69% and 35.03%, respectively.
Insider Trading News: Insiders at the company look optimistic about the outlook as they seem to accumulate shares while they have 18.51 jumped so far this year. A CEO & Chairman, 10% Owner at Opko Health, Inc. (OPK) purchased shares in a trading activity completed on Friday December 02, 2016. Frost Phillip Md Et Al accumulated 1,000 shares in the company at a per-share price of $10.49 and ended up spending $10,490 in the investment. Frost Phillip Md Et Al now have 184,000,000 shares in the stock after this transaction. A CEO & Chairman, 10% Owner in the company, Frost Phillip Md Et Al, on Thursday December 01, 2016 spent $39,030 from the purchase of 3,800 shares at a per-share price of $10.49. Insiders are expected to have better knowledge about the health and prospects of their company, which is why insiders’ move deserves attention.
Historical Quarterly Earnings: Last quarter, Opko Health, Inc. generated nearly $298.04M in sales and net income of -$0.03/share. That compares with the mean forecast $322M and -$0.03/share, respectively. For the prior quarter revenue for the stock hit $357.1M, with EPS at $0.02.
Opko Health, Inc. (OPK) Analyst Rating News
Standpoint Research is following shares of Opko Health, Inc. (OPK), so its rating change is noteworthy. The company stock was initiated at Buy, wrote analysts at Standpoint Research, in a research note issued to clients on Friday June 03, 2016. There was another key research note provided by JP Morgan on Friday October 16, 2015. The firm launched coverage on OPK at Overweight.
Price Potential: Even though the stock has posted 2.85% rise in value, its new closing price reflects a -1.98% fall in value from company’s one year high of $12.15. The stock is currently holding above its 50-day SMA of $10.73 and above its 200-day SMA of $10.03. Over the last 3 months and over the last 6 months, the shares of Opko Health, Inc. (OPK), have changed 7.69% and 35.03%, respectively.